Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma

Head and Neck

Volumn 24, Issue 11, 2002, Pages 1004-1011

  Teknos, Theodoros N ^a   Cox, Claudell ^a   Yoo, Sirius ^a   Chepeha, Douglas B ^a   Wolf, Gregory T ^a   Bradford, Carol R ^a   Carey, Thomas E ^a   Fisher, Susan G ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Angiogenesis; Head and neck cancer; Organ preservation; Serum marker; VEGF

Indexed keywords

VASCULOTROPIN;

ADVANCED CANCER; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER SURVIVAL; CELL INFILTRATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KAPLAN MEIER METHOD; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; COHORT STUDIES; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION, PATHOLOGIC; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036838662     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.10163     Document Type: Article

References (28)

1. Folkman J. Angiogenesis and cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
2. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
3. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-364.
4. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 1995;146:1029-1039.
5. Fujisaki K, Mitsuyama K, Toyonaga A, Matsuo K, Tanikawa K. Circulating vascular endothelial growth factor in patients with colorectal cancer. Am J Gastroenterol 1998;93:249-252.
6. Salven P, Ruotsalaine NT, Mattson K, Joennsu H. High pretreatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small cell lung cancer. Int J Cancer 1998;79:144-146.
7. Salven P, Heikkila P, Joennsu H. Enhanced expression of vascular endothelial growth factor in metastatic melanoma. Br J Cancer 1997;76:930-934.
8. Salven P, Teerenhovi L, Joennsu H. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma. Blood 1997;90:3167-3172.
9. Takano S, Yoshii Y, Kondo S, et al. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res 1996;56:2185-2190.
10. Vermeulen PB, Dirix LH, Martin M, Lemmens J, Van Oosterom AT. Serum basic fibroblast growth factor and vascular endothelial growth factor in metastatic renal cell carcinoma treated with interferon alfa-2b. J Natl Cancer Inst 1997;89:1316-1317.
11. Qian CN, Zhang CQ, Guo X, et al. Elevation of serum vascular endothelial growth factor in male patients with metastatic nasopharyngeal carcinoma. Cancer 2000;88:255-261.
12. Wolf GT, Hong WK, Fisher S, et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324:1685-1690.
13. Jakobsson PA. Histologic classification in grading of malignancy in carcinoma of the larynx. Acta Radiol 1973;12:1-8.
14. Hefler L, Tempfer C, Obermair A, et al. Serum concentrations of vascular endothelial growth factor in vulvar cancer. Clin Cancer Res 1999;5:2806-2809.
15. Neufeld G, Cohen T, Gitay-Goren H, et al. Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants. Cancer Metastasis Rev 1996;15:153-158.
16. Terman B, Dougher-Vermazen M. Biologic properties of VEGF/VPF receptors. Cancer Metastasis Rev 1996;15:159-163.
17. Brown LF, Berse B, Jackman RW, et al. Increased expression of vascular permeability factor and its receptors in kidney and bladder carcinomas. Am J Pathol 1993;143:1255-1259.
18. Stein I, Neeman M, Shweiki D, Itin A, Keshet E. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol 1995;15:5363-5368.
19. Kumar H, Heer K, Lee PW, et al. Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer. Clin Cancer Res 1998;4:1279-1285.
20. Linderholm B, Tavelin B, Grankvist K, Henriksson R. Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma. J Clin Oncol 1998;16:3121-3128.
21. Jacobsen J, Rasmuson T, Grankvist K, Ljungberg B. Vascular endothelial growth factor as prognostic factor in renal cell carcinoma. J Urol 2000;163:343-347.
22. Eisma RJ, Spiro JD, Kreutzer DL. Role of angiogenic factors: Coexpression of interleukin-8 and vascular endothelial growth factor in patients with head and neck squamous carcinoma. Laryngoscope 1999;109:687-693.
23. Chen Z. Malhotra PS, Thomas GR, et al. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res 1999;5:1369-1379.
24. Kerbel RS, Viloria-Petit A, Klement G, Rak J. 'Accidental' anti-angiogenic drugs: Anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples. Eur J Cancer 2000;36:1248-1257.
25. Denekamp J. Endothelial cell proliferation as a novel approach to targeting tumour therapy. Br J Cancer 1982;45:136-139.
26. Kerbel RS. Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents. Bioessays 1991;13:31-36.
27. Baccala AA, Zhong H, Clift SM, et al. Serum vascular endothelial growth factor is a candidate biomarker of metastatic tumor response to ex vivo gene therapy of renal cell cancer. Urology 1998;51:327-332.
28. Verheul HM, Hoekman K, Luykx-de Bakker S, et al. Platelet: Transporter of vascular endothelial growth factor. Clin Cancer Res 1997;3:2187-2190.